Verzenio 100 MG tablet UU 14S
Ended Awarded Last action
- Contract number
- SPE2DR26FM9B1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,269
Award facts
- Contract value 100% obligated
- $21,269.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,269.13 to AmerisourceBergen Drug Corp for the supply of Verzenio 100 mg tablets (14-tablet units) on January 7, 2026, with a completion date of January 8, 2026. This competitively awarded, firm fixed-price contract includes no set-aside provisions and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Verzenio is a prescription oncology medication used in the treatment of certain breast cancers, reflecting the Defense Logistics Agency's pharmaceutical procurement needs for military healthcare systems.
This delivery order represents a task order under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the Defense Logistics Agency's Troop Support Medical division. The IDC, valued at up to $999,999,999.00 and extending through December 31, 2031, serves as a comprehensive global pharmaceutical supply vehicle enabling the delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military treatment facilities and veteran healthcare programs worldwide. AmerisourceBergen Drug Corp's consistent performance on federal pharmaceutical contracts demonstrates its capability to fulfill critical medical supply requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26FM9B1?
SPE2DR26FM9B1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FM9B1 worth?
The government has obligated $21,269 on SPE2DR26FM9B1.
Is contract SPE2DR26FM9B1 an order under another contract?
Yes. SPE2DR26FM9B1 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM9B1 competed?
The extent of competition for SPE2DR26FM9B1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award